Yukio Ohya

Title: Yukio Ohya: Innovator in Antitumor Research

Introduction

Yukio Ohya is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antitumor agents. With a total of 4 patents to his name, Ohya's work focuses on enhancing the efficacy of natural killer cell activators.

Latest Patents

Ohya's latest patents include a groundbreaking invention related to recombinant natural killer cell activators. This invention discloses a recombinant natural killer cell activating factor, which is characterized by a specific peptide sequence. The patent provides a cDNA coding for this factor, along with an expression plasmid that incorporates the cDNA. Additionally, it describes a host transformed with the plasmid, an antitumor agent containing the recombinant factor, and a pharmaceutical composition that includes a pharmacologically effective amount of the antitumor agent combined with a pharmacologically acceptable carrier.

Career Highlights

Yukio Ohya is currently associated with Eisai Company, Limited, where he continues to advance his research in the field of biotechnology. His innovative work has the potential to significantly impact cancer treatment and improve patient outcomes.

Collaborations

Ohya has collaborated with notable colleagues in his field, including Kentaro Yoshimatsu and Yasushi Shikata. These collaborations have further enriched his research and contributed to the development of effective therapeutic solutions.

Conclusion

Yukio Ohya stands out as a key figure in the realm of antitumor research, with his innovative patents paving the way for future advancements in cancer therapy. His dedication to improving healthcare through biotechnology is commendable and continues to inspire others in the field.